GPATCH11
G patch domain-containing protein 11
Also known as: GPT11_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q8N954
- Gene
- GPATCH11
- Canonical length
- 285 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for GPATCH11 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
285 residues, UniProt reviewed canonical sequence.
>Q8N954|GPATCH11
1 MRSARSTALN RGEQRAVRYY SHMKLNMAEE EDYMSDSFIN VQEDIRPGLP MLRQIREARR
61 KEEKQQEANL KNRQKSLKEE EQERRDIGLK NALGCENKGF ALLQKMGYKS GQALGKSGGG
121 IVEPIPLNIK TGKSGIGHEA SLKRKAEEKL ESYRKKIHMK NQAEEKAAEQ FRMRLKNKQD
181 EMKLEGDLRR SQRACQQLDV QKNIQVPREA WYWLRLEEET EEDEEEKEQD EDEYKSEDLS
241 VLEKLQILTS YLREEHLYCI WCGTAYEDKE DLSSNCPGPT SADHDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPATCH11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 22 nTPM
- retina: 20 nTPM
- lymph node: 12 nTPM
- cerebral cortex: 11 nTPM
- tonsil: 11 nTPM
- testis: 11 nTPM
Single-cell type
- late primary spermatocytes: 106 nCPM
- early primary spermatocytes: 64 nCPM
- rod photoreceptor cells: 62 nCPM
- pdcs: 62 nCPM
- erythrocyte progenitors: 58 nCPM
- oocytes: 55 nCPM
Immune cell
- plasmacytoid DC: 12 nTPM
- memory B-cell: 8.4 nTPM
- naive B-cell: 6.7 nTPM
- NK-cell: 6.7 nTPM
- basophil: 5.8 nTPM
- MAIT T-cell: 4.4 nTPM
Brain region
- white matter: 18 nTPM
- hypothalamus: 15 nTPM
- cerebellum: 15 nTPM
- spinal cord: 15 nTPM
- medulla oblongata: 15 nTPM
- basal ganglia: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GPATCH11.
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 51 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Early onset and severe retinal dystrophy with neurological impairment and facial dysmorphia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- G-patch domain
- G-patch domain
- Domain of unknown function DUF4187
- G patch domain-containing protein 11
- Domain of unknown function (DUF4187)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GPATCH11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPATCH11 as an antibody target. Whether an autoantibody or antibody against GPATCH11 could matter depends on whether native GPATCH11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPATCH11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GPATCH11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...